Top Markets
#1 XPIN Network XPIN Network +21.86%
#2 Pons Pons +21.59%
#3 Geodnet Geodnet +20.76%
#4 The Black Bull The Black Bull +20.68%
#5 SSV Network SSV Network +19.58%
#6 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +19.58%
#7 Ore Ore +19.40%
#8 Derive Derive +18.88%
#9 Bitcoin Cash Bitcoin Cash +18.39%
#10 WhiteBIT Coin WhiteBIT Coin +18.09%
Coin of the day
XPIN Network XPIN Network
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Orexo AB Orexo AB

Orexo AB

ORX
Hisse Senetlerindeki Sıralama #24964
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Hisse Fiyatı
$1.56
Piyasa Değeri
$54.77M
Değişim (1 gün)
-0.43%
Değişim (1 yıl)
-29.25%
Ülke
SE
Ticaret Orexo AB (ORX)

Kategori

Healthcare
Orexo AB (ORX) için kazanç
2026 itibarıyla kazanç TTM: 0
Orexo AB şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Orexo AB için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK